Dr. Fabian Kausche Joins FidoCure Advisory Board
Leading Animal Health Expert Dr. Fabian Kausche Joins FidoCure Advisory Board
Unlocking Precision Oncology: Insights from Top Articles & Canine Cancer Studies
Precision medicine revolutionizes cancer care by tailoring treatments to each patient’s tumor, but major roadblocks remain. These top articles dive into the key challenges holding personalized oncology back and emerging solutions companies like FidoCure are exploring. You’ll find insights on innovative clinical trial designs, cutting-edge technologies enabling more precise therapies, and even how studying cancer […]
Understanding Hemangiosarcoma in Dogs: Treatment Options and Prognosis
Hemangiosarcoma is an aggressive, malignant tumor derived from blood vessel cells that grows rapidly, can cause severe bleeding, and has a high metastasis rate. It most commonly affects the spleen but can also occur in the heart, skin, and liver, with certain breeds like German Shepherds, Golden Retrievers, and Labradors at higher risk. Treatment typically […]
Small Molecules, Big Impact: An Interview with Dr. Cheryl London
Explore the history and impact of small molecules in this fascinating discussion. FidoCure’s Chief Medical Officer, Dr. Gerry Post interviews Dr. Cheryl London about their application in canine cancer treatment. Dr. Cheryl London is a world-renowned expert in veterinary oncology and targeted cancer therapies at Tufts University. Her pioneering work began in 2000 when she […]
FidoCure Brings Precision Medicine to the Forefront of Canine Cancer
One out of four pet dogs will be diagnosed with cancer throughout their lifetime. With nearly 6 million new canine cancer diagnoses each year, there is an urgent need for advanced treatments. Fortunately, FidoCure introduces advanced options into the cancer treatment toolbox for veterinarians and dogs, offering hope for improved outcomes.
FidoCure CEO Christina Lopes to Showcase World’s First Portfolio of Canine Cancer Drugs at 2024 Animal Health Summit
FidoCure CEO Christina Lopes will present at the 2024 Animal Health Summit in Kansas City on August 26-27. The summit will showcase emerging companies and foster connections between innovators, investors, and industry leaders in animal health, nutrition, and technology. Attendees can also expect 1:1 business partnering opportunities, interactive experiences, and presentations from some of the […]
Understanding Mast Cell Tumors in Dogs
Mast cell tumors are the most common skin tumors in dogs, developing from abnormal growth of mast cells, which are normally involved in allergic and immune responses. Treatment depends on tumor grade, size, and spread, ranging from surgery to radiation therapy to systemic therapies like chemotherapy and/or targeted therapy. Low-grade tumors that are completely removed […]
Canine Cancer Osteosarcoma Research
In our relentless pursuit of advancements in veterinary oncology, the FidoCure Team’s research has taken center stage, offering an in-depth exploration into the realm of canine osteosarcoma. The use of real-world data and machine learning techniques promises to provide invaluable insights into the mutation patterns and treatment outcomes associated with this challenging condition.
What to Know About Pulmonary Adenocarcinoma
Pulmonary adenocarcinoma is a common and aggressive form of lung cancer in dogs, accounting for nearly 80% of canine lung neoplasia cases. The primary treatment is surgical tumor removal, sometimes combined with chemotherapy or radiation therapy for inoperable cases. Prognosis depends on tumor size and grade, ranging from over 16 months for small, low-grade tumors […]
FidoCure Celebrates National Dog Day
Happy National Dog Day from all of us at FidoCure! Today, we celebrate the joy, companionship, and unconditional love that dogs bring into our lives. At FidoCure, our mission is to ensure that these beloved companions live longer, happier, and healthier lives, even when faced with the challenge of cancer.